Thematic Review Series
Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases: Thematic Review Series: Biology of Lipid Rafts

https://doi.org/10.1194/jlr.TR119000427Get rights and content
Under a Creative Commons license
open access

Lipid rafts are small, dynamic membrane areas characterized by the clustering of selected membrane lipids as the result of the spontaneous separation of glycolipids, sphingolipids, and cholesterol in a liquid-ordered phase. The exact dynamics underlying phase separation of membrane lipids in the complex biological membranes are still not fully understood. Nevertheless, alterations in the membrane lipid composition affect the lateral organization of molecules belonging to lipid rafts. Neural lipid rafts are found in brain cells, including neurons, astrocytes, and microglia, and are characterized by a high enrichment of specific lipids depending on the cell type. These lipid rafts seem to organize and determine the function of multiprotein complexes involved in several aspects of signal transduction, thus regulating the homeostasis of the brain. The progressive decline of brain performance along with physiological aging is at least in part associated with alterations in the composition and structure of neural lipid rafts. In addition, neurodegenerative conditions, such as lysosomal storage disorders, multiple sclerosis, and Parkinson's, Huntington's, and Alzheimer's diseases, are frequently characterized by dysregulated lipid metabolism, which in turn affects the structure of lipid rafts. Several events underlying the pathogenesis of these diseases appear to depend on the altered composition of lipid rafts. Thus, the structure and function of lipid rafts play a central role in the pathogenesis of many common neurodegenerative diseases.

lipid membrane domains
liquid-ordered phase
sphingolipids
gangliosides
cholesterol

Cited by (0)

The authors declare that they have no conflicts of interest with the contents of this article.

Ganglioside and glycosphingolipid nomenclature is in accordance with the IUPAC-IUBMB recommendations (1).